The Government of India has announced good news for critically ill patients. Those who are suffering from cancer are also under financial stress. Cancer treatment and medicine both are very costly. If someone in your family is going to treatment or diagnosed with cancer then you should read this article completely.
Cancer Medicines Prices will Reduce
Cases of Cancer in India are increasing every year. In 2019 a study which was published in the Lancet revealed India had 12 lakh new cancer cases in the same year. Out of which 9.3 lakh were dead. This is the second-highest cancer rate in Asia.
Last Friday Union Minister of State for Chemicals and Fertilisers stated the government has already mandated to decrease the MRP of all cancer medicines. For example, medicines like Derextecan, Darvalumab, Trastuzumab, and Ocimartinib prices will be lowered. Not only this but GST on these medicines is also lowered from 12% to 5%.
Companies instructed to lower Medicine Prices
All these steps are taken to give some financial help to cancer patients and their families. Anupriya Patel said, the manufacturers of these medicine manufacturers to lower their MRP. National Pharmaceutical Pricing Authority or NPPA has also been notified accordingly.
Benefits of these Request
Union Ministry of Chemicals and Fertilisers and AstraZeneca mentioned in the letter that as BCD is zero it will be affected after new stocks become available in the market. This will ease the financial burden of the patient’s family.
